Radio and PodcastRadio and PodcastLive Radio & Podcasts
Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma artwork
Science & Medicine

Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer by American Medical Association

Oct 24, 202420:41Science & Medicine

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD. Related Content: Anti–P...

Related Episodes

Continue listening to more episodes from JAMA Oncology Author Interviews: Covering research, science, & clinical practice in oncology that improves the care of patients with cancer.